|
|
Pleurisy root* | |
|
Calcium* Willow* | |
|
High-potassium foods* Potassium* | |
| Side effect reduction/prevention |
None known |
| Supportive interaction |
None known |
An asterisk (*) next to an item in the summary indicates that the interaction is supported only by weak, fragmentary, and/or contradictory scientific evidence.
Calcium
Calcium supplements, if taken at the same time as some beta-blocker drugs, may reduce blood
levels of the drug.1 However, whether calcium affects nadolol in this manner is
unknown. Until more information is available, people on nadolol should take calcium
supplements an hour before or two hours after the drug.
Potassium
People taking nadolol may experience significant increases in blood levels of
potassium,2 though it is unknown whether supplementation with potassium might
enhance this effect. People taking beta-blockers should therefore avoid taking potassium
supplements, or eating large quantities of fruit (e.g.,
bananas), unless directed to do so by their
doctor.
Pleurisy root
As pleurisy root and other plants in the Aesclepius genus contain cardiac glycosides,
it is best to avoid use of pleurisy root with heart medications such as
beta-blockers.3
Willow (Salix
alba)
The active compound in willow, salicin, is converted to salicylic acid in the body. Taking
salicylates with other beta-adrenergic blocking drugs has resulted in decreased absorption of
the drugs.4 Therefore, until more is known about the interaction between willow and
nadolol, they should not be taken at the same time.
1. Burnham TH, ed. Cardiovascular Agents, Antiadrenergics/Sympatholytics, Beta-Adrenergic Blocking Agents. In Facts and Comparisons Drug Information. St. Louis, MO: Facts and Comparisons, 2000, 467–79.
2. Wheeldon NM, McDevitt DG, Lipworth BJ. The effects of lower than conventional doses of oral nadolol on relative beta 1/beta 2-adrenoceptor blockade. Br J Clin Pharmacol 1994;38:103–8.
3. Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A Guide for Health-Care Professionals. London: Pharmaceutical Press, 1996, 213–4.
4. Burnham TH, ed. Cardiovascular Agents, Antiadrenergics/Sympatholytics, Beta-Adrenergic Blocking Agents. In Facts and Comparisons Drug Information. St. Louis, MO: Facts and Comparisons, 2000, 467–79.
| |||||||